AU4330097A - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
AU4330097A
AU4330097A AU43300/97A AU4330097A AU4330097A AU 4330097 A AU4330097 A AU 4330097A AU 43300/97 A AU43300/97 A AU 43300/97A AU 4330097 A AU4330097 A AU 4330097A AU 4330097 A AU4330097 A AU 4330097A
Authority
AU
Australia
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43300/97A
Other languages
English (en)
Inventor
Rima S. Al-Awar
William J. Ehlhardt
Subbaraju V. Gottumukkala
Michael J. Martinelli
Eric D. Moher
Richard E Moore
John E Munroe
Bryan H Norman
Vinod F. Patel
James E. Ray
Chuan Shih
John E. Toth
Venkatraghavan Vasudevan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wayne State University
Eli Lilly and Co
University of Hawaii at Hilo
Original Assignee
University of Hawaii at Manoa
Wayne State University
Eli Lilly and Co
University of Hawaii at Hilo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1996/013855 external-priority patent/WO1997007798A1/en
Application filed by University of Hawaii at Manoa, Wayne State University, Eli Lilly and Co, University of Hawaii at Hilo filed Critical University of Hawaii at Manoa
Publication of AU4330097A publication Critical patent/AU4330097A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU43300/97A 1996-08-30 1997-08-29 Pharmaceutical compounds Abandoned AU4330097A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
PCT/US1996/013855 WO1997007798A1 (en) 1995-08-30 1996-08-30 Pharmaceutical compounds
WO613855 1996-08-30
US3898997P 1997-02-26 1997-02-26
US60038989 1997-02-26
US3952997P 1997-03-03 1997-03-03
US60039529 1997-03-03
PCT/US1997/015245 WO1998008506A1 (en) 1996-08-30 1997-08-29 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
AU4330097A true AU4330097A (en) 1998-03-19

Family

ID=27365489

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43300/97A Abandoned AU4330097A (en) 1996-08-30 1997-08-29 Pharmaceutical compounds

Country Status (5)

Country Link
EP (1) EP0957912A1 (cg-RX-API-DMAC7.html)
JP (1) JP2001502297A (cg-RX-API-DMAC7.html)
AU (1) AU4330097A (cg-RX-API-DMAC7.html)
CA (1) CA2263420A1 (cg-RX-API-DMAC7.html)
WO (1) WO1998008506A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997023211A1 (en) * 1995-12-22 1997-07-03 Eli Lilly And Company Pharmaceutical compounds
JP2001500484A (ja) * 1996-08-30 2001-01-16 イーライ・リリー・アンド・カンパニー 医薬化合物の製造法
KR20010029474A (ko) * 1996-09-06 2001-04-06 피터 지. 스트링거 제약 화합물의 제조 방법
AU4253997A (en) * 1996-09-06 1998-03-26 Eli Lilly And Company Process and novel intermediates
PL335347A1 (en) * 1997-02-26 2000-04-25 Lilly Co Eli Selective epoxidising process for use in production of pharmaceutic compounds
AU6338698A (en) * 1997-02-26 1998-09-18 Eli Lilly And Company Tripeptide and tetrapeptide pharmaceutical compounds
US6180679B1 (en) * 1998-04-07 2001-01-30 Eli Lilly And Company Method for treating fungal infections
US6103913A (en) * 1998-10-16 2000-08-15 Eli Lilly And Company Process for preparing enollactone derivatives
US6376230B1 (en) 1998-10-16 2002-04-23 Eli Lilly And Company Stereoselective process for producing intermediates of cryptophycins
US7303749B1 (en) 1999-10-01 2007-12-04 Immunogen Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
EP2289549A3 (en) 1999-10-01 2011-06-15 Immunogen, Inc. Immunoconjugates for treating cancer
CA2513150A1 (en) * 2003-01-22 2004-08-05 Warner-Lambert Company Llc Cyclopropyl beta-amino acid derivatives
US8088387B2 (en) 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0735819B1 (en) * 1993-12-21 2001-07-11 University Of Hawaii Cryptophycins
JP2000507805A (ja) * 1995-08-30 2000-06-27 ユニバーシティ オブ ハワイ 変形生合成からのクリプトフィシン
EP0792875B1 (en) * 1996-02-27 2001-05-09 Eli Lilly And Company Cryptophycin derivatives and their use as anti-microtubule agents

Also Published As

Publication number Publication date
EP0957912A1 (en) 1999-11-24
CA2263420A1 (en) 1998-03-05
WO1998008506A1 (en) 1998-03-05
EP0957912A4 (cg-RX-API-DMAC7.html) 1999-12-22
JP2001502297A (ja) 2001-02-20

Similar Documents

Publication Publication Date Title
GB9602080D0 (en) Pharmaceutical compounds
AU4762797A (en) Pharmaceutical compositions
AU2967597A (en) Pharmaceutical compositions
AU6740298A (en) Pharmaceutical composition
AU2533495A (en) Pharmaceutical diketopiperazine compounds
AU2186797A (en) Pharmaceutically useful compounds
AU6904896A (en) Pharmaceutical compounds
AU3777897A (en) Pharmaceutical compositions
AU4925697A (en) Compounds
AU8591898A (en) Pharmaceutical compounds
AU4326197A (en) Pharmaceutical compositions
GB9609976D0 (en) Pharmaceutical compounds
AU4330097A (en) Pharmaceutical compounds
GB9621789D0 (en) Pharmaceutical compounds
AU2531295A (en) Pharmaceutical composition
AU9343098A (en) Pharmaceutical composition
AU4169897A (en) Pharmaceutical compounds
ZA979329B (en) Pharmaceutical compounds
AU6480299A (en) Pharmaceutical compounds
AU7546096A (en) Pharmaceutical compounds
GB9626151D0 (en) Pharmaceutical compounds
AU4457597A (en) Pharmaceutical compositions
AUPN862596A0 (en) Pharmaceutical compositions
AU5184599A (en) Pharmaceutical compounds
AU5330198A (en) Therapeutic compounds